nodes	percent_of_prediction	percent_of_DWPC	metapath
Sofosbuvir—Nucleoside Analog—Azathioprine—systemic scleroderma	0.743	1	CiPCiCtD
Sofosbuvir—ABCB1—Lisinopril—systemic scleroderma	0.0582	0.328	CbGbCtD
Sofosbuvir—ABCB1—Captopril—systemic scleroderma	0.0436	0.246	CbGbCtD
Sofosbuvir—ABCB1—Mycophenolate mofetil—systemic scleroderma	0.0343	0.194	CbGbCtD
Sofosbuvir—ABCB1—Prednisone—systemic scleroderma	0.0274	0.155	CbGbCtD
Sofosbuvir—ABCB1—Methotrexate—systemic scleroderma	0.0138	0.0776	CbGbCtD
Sofosbuvir—Mediastinal disorder—Lisinopril—systemic scleroderma	0.000219	0.00276	CcSEcCtD
Sofosbuvir—Chills—Lisinopril—systemic scleroderma	0.000218	0.00275	CcSEcCtD
Sofosbuvir—Dyspnoea—Captopril—systemic scleroderma	0.000218	0.00274	CcSEcCtD
Sofosbuvir—Anaemia—Mycophenolic acid—systemic scleroderma	0.000217	0.00274	CcSEcCtD
Sofosbuvir—Agitation—Mycophenolic acid—systemic scleroderma	0.000216	0.00272	CcSEcCtD
Sofosbuvir—Cough—Leflunomide—systemic scleroderma	0.000215	0.00271	CcSEcCtD
Sofosbuvir—Alopecia—Lisinopril—systemic scleroderma	0.000215	0.00271	CcSEcCtD
Sofosbuvir—Dyspepsia—Captopril—systemic scleroderma	0.000215	0.00271	CcSEcCtD
Sofosbuvir—Dizziness—Pentoxifylline—systemic scleroderma	0.000213	0.00268	CcSEcCtD
Sofosbuvir—Decreased appetite—Captopril—systemic scleroderma	0.000212	0.00267	CcSEcCtD
Sofosbuvir—Malnutrition—Lisinopril—systemic scleroderma	0.000212	0.00267	CcSEcCtD
Sofosbuvir—Infection—Azathioprine—systemic scleroderma	0.000212	0.00267	CcSEcCtD
Sofosbuvir—Fatigue—Captopril—systemic scleroderma	0.00021	0.00265	CcSEcCtD
Sofosbuvir—Chest pain—Leflunomide—systemic scleroderma	0.00021	0.00264	CcSEcCtD
Sofosbuvir—Arthralgia—Leflunomide—systemic scleroderma	0.00021	0.00264	CcSEcCtD
Sofosbuvir—Myalgia—Leflunomide—systemic scleroderma	0.00021	0.00264	CcSEcCtD
Sofosbuvir—Connective tissue disorder—Mycophenolate mofetil—systemic scleroderma	0.000209	0.00264	CcSEcCtD
Sofosbuvir—Anxiety—Leflunomide—systemic scleroderma	0.000209	0.00263	CcSEcCtD
Sofosbuvir—Constipation—Captopril—systemic scleroderma	0.000209	0.00263	CcSEcCtD
Sofosbuvir—Unspecified disorder of skin and subcutaneous tissue—Leflunomide—systemic scleroderma	0.000208	0.00263	CcSEcCtD
Sofosbuvir—Skin disorder—Azathioprine—systemic scleroderma	0.000207	0.00261	CcSEcCtD
Sofosbuvir—Dry mouth—Leflunomide—systemic scleroderma	0.000205	0.00259	CcSEcCtD
Sofosbuvir—Cough—Mycophenolic acid—systemic scleroderma	0.000205	0.00259	CcSEcCtD
Sofosbuvir—Back pain—Lisinopril—systemic scleroderma	0.000205	0.00258	CcSEcCtD
Sofosbuvir—Vomiting—Pentoxifylline—systemic scleroderma	0.000205	0.00258	CcSEcCtD
Sofosbuvir—Muscle spasms—Lisinopril—systemic scleroderma	0.000204	0.00257	CcSEcCtD
Sofosbuvir—Rash—Pentoxifylline—systemic scleroderma	0.000203	0.00256	CcSEcCtD
Sofosbuvir—Dermatitis—Pentoxifylline—systemic scleroderma	0.000203	0.00256	CcSEcCtD
Sofosbuvir—Headache—Pentoxifylline—systemic scleroderma	0.000202	0.00254	CcSEcCtD
Sofosbuvir—Myalgia—Mycophenolic acid—systemic scleroderma	0.0002	0.00252	CcSEcCtD
Sofosbuvir—Chest pain—Mycophenolic acid—systemic scleroderma	0.0002	0.00252	CcSEcCtD
Sofosbuvir—Arthralgia—Mycophenolic acid—systemic scleroderma	0.0002	0.00252	CcSEcCtD
Sofosbuvir—Infection—Leflunomide—systemic scleroderma	0.0002	0.00252	CcSEcCtD
Sofosbuvir—Vision blurred—Lisinopril—systemic scleroderma	0.0002	0.00251	CcSEcCtD
Sofosbuvir—Anxiety—Mycophenolic acid—systemic scleroderma	0.000199	0.00251	CcSEcCtD
Sofosbuvir—Asthenia—Mometasone—systemic scleroderma	0.000199	0.00251	CcSEcCtD
Sofosbuvir—Irritability—Prednisone—systemic scleroderma	0.000199	0.00251	CcSEcCtD
Sofosbuvir—Eye disorder—Mycophenolate mofetil—systemic scleroderma	0.000199	0.00251	CcSEcCtD
Sofosbuvir—Unspecified disorder of skin and subcutaneous tissue—Mycophenolic acid—systemic scleroderma	0.000199	0.0025	CcSEcCtD
Sofosbuvir—Nervous system disorder—Leflunomide—systemic scleroderma	0.000197	0.00249	CcSEcCtD
Sofosbuvir—Pruritus—Mometasone—systemic scleroderma	0.000197	0.00248	CcSEcCtD
Sofosbuvir—Dry mouth—Mycophenolic acid—systemic scleroderma	0.000196	0.00247	CcSEcCtD
Sofosbuvir—Anaemia—Lisinopril—systemic scleroderma	0.000196	0.00247	CcSEcCtD
Sofosbuvir—Skin disorder—Leflunomide—systemic scleroderma	0.000195	0.00246	CcSEcCtD
Sofosbuvir—Musculoskeletal discomfort—Azathioprine—systemic scleroderma	0.000194	0.00245	CcSEcCtD
Sofosbuvir—Body temperature increased—Captopril—systemic scleroderma	0.000193	0.00243	CcSEcCtD
Sofosbuvir—Mediastinal disorder—Mycophenolate mofetil—systemic scleroderma	0.000192	0.00242	CcSEcCtD
Sofosbuvir—Dry skin—Prednisone—systemic scleroderma	0.000191	0.00241	CcSEcCtD
Sofosbuvir—Nausea—Pentoxifylline—systemic scleroderma	0.000191	0.00241	CcSEcCtD
Sofosbuvir—Chills—Mycophenolate mofetil—systemic scleroderma	0.000191	0.00241	CcSEcCtD
Sofosbuvir—Infection—Mycophenolic acid—systemic scleroderma	0.000191	0.0024	CcSEcCtD
Sofosbuvir—Diarrhoea—Mometasone—systemic scleroderma	0.00019	0.0024	CcSEcCtD
Sofosbuvir—Alopecia—Mycophenolate mofetil—systemic scleroderma	0.000188	0.00237	CcSEcCtD
Sofosbuvir—Nervous system disorder—Mycophenolic acid—systemic scleroderma	0.000188	0.00237	CcSEcCtD
Sofosbuvir—Skin disorder—Mycophenolic acid—systemic scleroderma	0.000186	0.00235	CcSEcCtD
Sofosbuvir—Malnutrition—Mycophenolate mofetil—systemic scleroderma	0.000186	0.00234	CcSEcCtD
Sofosbuvir—Cough—Lisinopril—systemic scleroderma	0.000185	0.00233	CcSEcCtD
Sofosbuvir—Gastrointestinal disorder—Azathioprine—systemic scleroderma	0.000184	0.00232	CcSEcCtD
Sofosbuvir—Musculoskeletal discomfort—Leflunomide—systemic scleroderma	0.000183	0.00231	CcSEcCtD
Sofosbuvir—Insomnia—Leflunomide—systemic scleroderma	0.000182	0.00229	CcSEcCtD
Sofosbuvir—Myalgia—Lisinopril—systemic scleroderma	0.00018	0.00227	CcSEcCtD
Sofosbuvir—Chest pain—Lisinopril—systemic scleroderma	0.00018	0.00227	CcSEcCtD
Sofosbuvir—Arthralgia—Lisinopril—systemic scleroderma	0.00018	0.00227	CcSEcCtD
Sofosbuvir—Anxiety—Lisinopril—systemic scleroderma	0.00018	0.00226	CcSEcCtD
Sofosbuvir—Back pain—Mycophenolate mofetil—systemic scleroderma	0.000179	0.00226	CcSEcCtD
Sofosbuvir—Dyspnoea—Leflunomide—systemic scleroderma	0.000179	0.00226	CcSEcCtD
Sofosbuvir—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—systemic scleroderma	0.000179	0.00226	CcSEcCtD
Sofosbuvir—Muscle spasms—Mycophenolate mofetil—systemic scleroderma	0.000178	0.00225	CcSEcCtD
Sofosbuvir—Dyspepsia—Leflunomide—systemic scleroderma	0.000177	0.00223	CcSEcCtD
Sofosbuvir—Vomiting—Mometasone—systemic scleroderma	0.000177	0.00223	CcSEcCtD
Sofosbuvir—Dry mouth—Lisinopril—systemic scleroderma	0.000176	0.00222	CcSEcCtD
Sofosbuvir—Rash—Mometasone—systemic scleroderma	0.000175	0.00221	CcSEcCtD
Sofosbuvir—Asthenia—Captopril—systemic scleroderma	0.000175	0.00221	CcSEcCtD
Sofosbuvir—Dermatitis—Mometasone—systemic scleroderma	0.000175	0.00221	CcSEcCtD
Sofosbuvir—Decreased appetite—Leflunomide—systemic scleroderma	0.000175	0.0022	CcSEcCtD
Sofosbuvir—Musculoskeletal discomfort—Mycophenolic acid—systemic scleroderma	0.000175	0.0022	CcSEcCtD
Sofosbuvir—Headache—Mometasone—systemic scleroderma	0.000174	0.00219	CcSEcCtD
Sofosbuvir—Gastrointestinal disorder—Leflunomide—systemic scleroderma	0.000174	0.00219	CcSEcCtD
Sofosbuvir—Insomnia—Mycophenolic acid—systemic scleroderma	0.000174	0.00219	CcSEcCtD
Sofosbuvir—Fatigue—Leflunomide—systemic scleroderma	0.000173	0.00219	CcSEcCtD
Sofosbuvir—Pruritus—Captopril—systemic scleroderma	0.000173	0.00218	CcSEcCtD
Sofosbuvir—Pain—Leflunomide—systemic scleroderma	0.000172	0.00217	CcSEcCtD
Sofosbuvir—Constipation—Leflunomide—systemic scleroderma	0.000172	0.00217	CcSEcCtD
Sofosbuvir—Infection—Lisinopril—systemic scleroderma	0.000172	0.00216	CcSEcCtD
Sofosbuvir—Anaemia—Mycophenolate mofetil—systemic scleroderma	0.000171	0.00216	CcSEcCtD
Sofosbuvir—Dyspnoea—Mycophenolic acid—systemic scleroderma	0.000171	0.00216	CcSEcCtD
Sofosbuvir—Agitation—Mycophenolate mofetil—systemic scleroderma	0.00017	0.00215	CcSEcCtD
Sofosbuvir—Dyspepsia—Mycophenolic acid—systemic scleroderma	0.000169	0.00213	CcSEcCtD
Sofosbuvir—Neutropenia—Prednisone—systemic scleroderma	0.000169	0.00213	CcSEcCtD
Sofosbuvir—Body temperature increased—Azathioprine—systemic scleroderma	0.000168	0.00212	CcSEcCtD
Sofosbuvir—Skin disorder—Lisinopril—systemic scleroderma	0.000168	0.00212	CcSEcCtD
Sofosbuvir—Diarrhoea—Captopril—systemic scleroderma	0.000167	0.0021	CcSEcCtD
Sofosbuvir—Decreased appetite—Mycophenolic acid—systemic scleroderma	0.000167	0.0021	CcSEcCtD
Sofosbuvir—Irritability—Methotrexate—systemic scleroderma	0.000167	0.0021	CcSEcCtD
Sofosbuvir—Gastrointestinal disorder—Mycophenolic acid—systemic scleroderma	0.000166	0.00209	CcSEcCtD
Sofosbuvir—Fatigue—Mycophenolic acid—systemic scleroderma	0.000165	0.00208	CcSEcCtD
Sofosbuvir—Nausea—Mometasone—systemic scleroderma	0.000165	0.00208	CcSEcCtD
Sofosbuvir—Pain—Mycophenolic acid—systemic scleroderma	0.000164	0.00207	CcSEcCtD
Sofosbuvir—Constipation—Mycophenolic acid—systemic scleroderma	0.000164	0.00207	CcSEcCtD
Sofosbuvir—Weight decreased—Prednisone—systemic scleroderma	0.000163	0.00206	CcSEcCtD
Sofosbuvir—Cough—Mycophenolate mofetil—systemic scleroderma	0.000162	0.00204	CcSEcCtD
Sofosbuvir—Dizziness—Captopril—systemic scleroderma	0.000161	0.00203	CcSEcCtD
Sofosbuvir—Body temperature increased—Leflunomide—systemic scleroderma	0.000159	0.002	CcSEcCtD
Sofosbuvir—Myalgia—Mycophenolate mofetil—systemic scleroderma	0.000158	0.00199	CcSEcCtD
Sofosbuvir—Chest pain—Mycophenolate mofetil—systemic scleroderma	0.000158	0.00199	CcSEcCtD
Sofosbuvir—Arthralgia—Mycophenolate mofetil—systemic scleroderma	0.000158	0.00199	CcSEcCtD
Sofosbuvir—Musculoskeletal discomfort—Lisinopril—systemic scleroderma	0.000157	0.00198	CcSEcCtD
Sofosbuvir—Anxiety—Mycophenolate mofetil—systemic scleroderma	0.000157	0.00198	CcSEcCtD
Sofosbuvir—Unspecified disorder of skin and subcutaneous tissue—Mycophenolate mofetil—systemic scleroderma	0.000157	0.00198	CcSEcCtD
Sofosbuvir—Insomnia—Lisinopril—systemic scleroderma	0.000156	0.00197	CcSEcCtD
Sofosbuvir—Vomiting—Captopril—systemic scleroderma	0.000155	0.00196	CcSEcCtD
Sofosbuvir—Dry mouth—Mycophenolate mofetil—systemic scleroderma	0.000154	0.00195	CcSEcCtD
Sofosbuvir—Dyspnoea—Lisinopril—systemic scleroderma	0.000154	0.00194	CcSEcCtD
Sofosbuvir—Rash—Captopril—systemic scleroderma	0.000154	0.00194	CcSEcCtD
Sofosbuvir—Dermatitis—Captopril—systemic scleroderma	0.000154	0.00194	CcSEcCtD
Sofosbuvir—Headache—Captopril—systemic scleroderma	0.000153	0.00193	CcSEcCtD
Sofosbuvir—Dyspepsia—Lisinopril—systemic scleroderma	0.000152	0.00192	CcSEcCtD
Sofosbuvir—Body temperature increased—Mycophenolic acid—systemic scleroderma	0.000152	0.00191	CcSEcCtD
Sofosbuvir—Infection—Mycophenolate mofetil—systemic scleroderma	0.00015	0.0019	CcSEcCtD
Sofosbuvir—Decreased appetite—Lisinopril—systemic scleroderma	0.00015	0.00189	CcSEcCtD
Sofosbuvir—Gastrointestinal disorder—Lisinopril—systemic scleroderma	0.000149	0.00188	CcSEcCtD
Sofosbuvir—Fatigue—Lisinopril—systemic scleroderma	0.000149	0.00188	CcSEcCtD
Sofosbuvir—Nervous system disorder—Mycophenolate mofetil—systemic scleroderma	0.000148	0.00187	CcSEcCtD
Sofosbuvir—Constipation—Lisinopril—systemic scleroderma	0.000148	0.00186	CcSEcCtD
Sofosbuvir—Pain—Lisinopril—systemic scleroderma	0.000148	0.00186	CcSEcCtD
Sofosbuvir—Skin disorder—Mycophenolate mofetil—systemic scleroderma	0.000147	0.00185	CcSEcCtD
Sofosbuvir—Diarrhoea—Azathioprine—systemic scleroderma	0.000146	0.00184	CcSEcCtD
Sofosbuvir—Nausea—Captopril—systemic scleroderma	0.000145	0.00183	CcSEcCtD
Sofosbuvir—Abdominal discomfort—Methotrexate—systemic scleroderma	0.000145	0.00182	CcSEcCtD
Sofosbuvir—Asthenia—Leflunomide—systemic scleroderma	0.000144	0.00182	CcSEcCtD
Sofosbuvir—Pancytopenia—Methotrexate—systemic scleroderma	0.000143	0.00181	CcSEcCtD
Sofosbuvir—Pruritus—Leflunomide—systemic scleroderma	0.000142	0.00179	CcSEcCtD
Sofosbuvir—Connective tissue disorder—Prednisone—systemic scleroderma	0.000142	0.00179	CcSEcCtD
Sofosbuvir—Neutropenia—Methotrexate—systemic scleroderma	0.000141	0.00178	CcSEcCtD
Sofosbuvir—Dizziness—Azathioprine—systemic scleroderma	0.000141	0.00177	CcSEcCtD
Sofosbuvir—Musculoskeletal discomfort—Mycophenolate mofetil—systemic scleroderma	0.000138	0.00174	CcSEcCtD
Sofosbuvir—Asthenia—Mycophenolic acid—systemic scleroderma	0.000138	0.00173	CcSEcCtD
Sofosbuvir—Diarrhoea—Leflunomide—systemic scleroderma	0.000138	0.00173	CcSEcCtD
Sofosbuvir—Insomnia—Mycophenolate mofetil—systemic scleroderma	0.000137	0.00173	CcSEcCtD
Sofosbuvir—Body temperature increased—Lisinopril—systemic scleroderma	0.000137	0.00172	CcSEcCtD
Sofosbuvir—Pruritus—Mycophenolic acid—systemic scleroderma	0.000136	0.00171	CcSEcCtD
Sofosbuvir—Vomiting—Azathioprine—systemic scleroderma	0.000135	0.00171	CcSEcCtD
Sofosbuvir—Eye disorder—Prednisone—systemic scleroderma	0.000135	0.0017	CcSEcCtD
Sofosbuvir—Dyspnoea—Mycophenolate mofetil—systemic scleroderma	0.000135	0.0017	CcSEcCtD
Sofosbuvir—Infestation NOS—Methotrexate—systemic scleroderma	0.000134	0.00169	CcSEcCtD
Sofosbuvir—Infestation—Methotrexate—systemic scleroderma	0.000134	0.00169	CcSEcCtD
Sofosbuvir—Rash—Azathioprine—systemic scleroderma	0.000134	0.00169	CcSEcCtD
Sofosbuvir—Dermatitis—Azathioprine—systemic scleroderma	0.000134	0.00169	CcSEcCtD
Sofosbuvir—Headache—Azathioprine—systemic scleroderma	0.000133	0.00168	CcSEcCtD
Sofosbuvir—Dyspepsia—Mycophenolate mofetil—systemic scleroderma	0.000133	0.00168	CcSEcCtD
Sofosbuvir—Dizziness—Leflunomide—systemic scleroderma	0.000133	0.00168	CcSEcCtD
Sofosbuvir—Decreased appetite—Mycophenolate mofetil—systemic scleroderma	0.000132	0.00166	CcSEcCtD
Sofosbuvir—Diarrhoea—Mycophenolic acid—systemic scleroderma	0.000131	0.00165	CcSEcCtD
Sofosbuvir—Gastrointestinal disorder—Mycophenolate mofetil—systemic scleroderma	0.000131	0.00165	CcSEcCtD
Sofosbuvir—Pain—Mycophenolate mofetil—systemic scleroderma	0.000129	0.00163	CcSEcCtD
Sofosbuvir—Constipation—Mycophenolate mofetil—systemic scleroderma	0.000129	0.00163	CcSEcCtD
Sofosbuvir—Vomiting—Leflunomide—systemic scleroderma	0.000128	0.00161	CcSEcCtD
Sofosbuvir—Alopecia—Prednisone—systemic scleroderma	0.000128	0.00161	CcSEcCtD
Sofosbuvir—Hepatobiliary disease—Methotrexate—systemic scleroderma	0.000127	0.0016	CcSEcCtD
Sofosbuvir—Dizziness—Mycophenolic acid—systemic scleroderma	0.000127	0.0016	CcSEcCtD
Sofosbuvir—Rash—Leflunomide—systemic scleroderma	0.000127	0.0016	CcSEcCtD
Sofosbuvir—Dermatitis—Leflunomide—systemic scleroderma	0.000127	0.0016	CcSEcCtD
Sofosbuvir—Nausea—Azathioprine—systemic scleroderma	0.000127	0.00159	CcSEcCtD
Sofosbuvir—Headache—Leflunomide—systemic scleroderma	0.000126	0.00159	CcSEcCtD
Sofosbuvir—Malnutrition—Prednisone—systemic scleroderma	0.000126	0.00158	CcSEcCtD
Sofosbuvir—Asthenia—Lisinopril—systemic scleroderma	0.000124	0.00156	CcSEcCtD
Sofosbuvir—Pruritus—Lisinopril—systemic scleroderma	0.000122	0.00154	CcSEcCtD
Sofosbuvir—Vomiting—Mycophenolic acid—systemic scleroderma	0.000122	0.00154	CcSEcCtD
Sofosbuvir—Rash—Mycophenolic acid—systemic scleroderma	0.000121	0.00152	CcSEcCtD
Sofosbuvir—Dermatitis—Mycophenolic acid—systemic scleroderma	0.000121	0.00152	CcSEcCtD
Sofosbuvir—Headache—Mycophenolic acid—systemic scleroderma	0.00012	0.00151	CcSEcCtD
Sofosbuvir—Body temperature increased—Mycophenolate mofetil—systemic scleroderma	0.00012	0.00151	CcSEcCtD
Sofosbuvir—Nausea—Leflunomide—systemic scleroderma	0.000119	0.00151	CcSEcCtD
Sofosbuvir—Vision blurred—Prednisone—systemic scleroderma	0.000119	0.00149	CcSEcCtD
Sofosbuvir—Diarrhoea—Lisinopril—systemic scleroderma	0.000118	0.00149	CcSEcCtD
Sofosbuvir—Anaemia—Prednisone—systemic scleroderma	0.000116	0.00146	CcSEcCtD
Sofosbuvir—Agitation—Prednisone—systemic scleroderma	0.000116	0.00146	CcSEcCtD
Sofosbuvir—Dizziness—Lisinopril—systemic scleroderma	0.000114	0.00144	CcSEcCtD
Sofosbuvir—Nausea—Mycophenolic acid—systemic scleroderma	0.000114	0.00144	CcSEcCtD
Sofosbuvir—Eye disorder—Methotrexate—systemic scleroderma	0.000113	0.00142	CcSEcCtD
Sofosbuvir—Vomiting—Lisinopril—systemic scleroderma	0.00011	0.00138	CcSEcCtD
Sofosbuvir—Rash—Lisinopril—systemic scleroderma	0.000109	0.00137	CcSEcCtD
Sofosbuvir—Dermatitis—Lisinopril—systemic scleroderma	0.000109	0.00137	CcSEcCtD
Sofosbuvir—Mediastinal disorder—Methotrexate—systemic scleroderma	0.000109	0.00137	CcSEcCtD
Sofosbuvir—Asthenia—Mycophenolate mofetil—systemic scleroderma	0.000109	0.00137	CcSEcCtD
Sofosbuvir—Chills—Methotrexate—systemic scleroderma	0.000108	0.00137	CcSEcCtD
Sofosbuvir—Headache—Lisinopril—systemic scleroderma	0.000108	0.00136	CcSEcCtD
Sofosbuvir—Pruritus—Mycophenolate mofetil—systemic scleroderma	0.000107	0.00135	CcSEcCtD
Sofosbuvir—Arthralgia—Prednisone—systemic scleroderma	0.000107	0.00135	CcSEcCtD
Sofosbuvir—Myalgia—Prednisone—systemic scleroderma	0.000107	0.00135	CcSEcCtD
Sofosbuvir—Anxiety—Prednisone—systemic scleroderma	0.000107	0.00134	CcSEcCtD
Sofosbuvir—Alopecia—Methotrexate—systemic scleroderma	0.000107	0.00134	CcSEcCtD
Sofosbuvir—Unspecified disorder of skin and subcutaneous tissue—Prednisone—systemic scleroderma	0.000106	0.00134	CcSEcCtD
Sofosbuvir—Malnutrition—Methotrexate—systemic scleroderma	0.000105	0.00132	CcSEcCtD
Sofosbuvir—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	0.000104	0.00131	CcSEcCtD
Sofosbuvir—Nausea—Lisinopril—systemic scleroderma	0.000103	0.00129	CcSEcCtD
Sofosbuvir—Infection—Prednisone—systemic scleroderma	0.000102	0.00129	CcSEcCtD
Sofosbuvir—Back pain—Methotrexate—systemic scleroderma	0.000102	0.00128	CcSEcCtD
Sofosbuvir—Nervous system disorder—Prednisone—systemic scleroderma	0.000101	0.00127	CcSEcCtD
Sofosbuvir—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.0001	0.00126	CcSEcCtD
Sofosbuvir—Skin disorder—Prednisone—systemic scleroderma	9.97e-05	0.00126	CcSEcCtD
Sofosbuvir—Vision blurred—Methotrexate—systemic scleroderma	9.91e-05	0.00125	CcSEcCtD
Sofosbuvir—Anaemia—Methotrexate—systemic scleroderma	9.71e-05	0.00122	CcSEcCtD
Sofosbuvir—Vomiting—Mycophenolate mofetil—systemic scleroderma	9.63e-05	0.00121	CcSEcCtD
Sofosbuvir—Rash—Mycophenolate mofetil—systemic scleroderma	9.55e-05	0.0012	CcSEcCtD
Sofosbuvir—Dermatitis—Mycophenolate mofetil—systemic scleroderma	9.54e-05	0.0012	CcSEcCtD
Sofosbuvir—Headache—Mycophenolate mofetil—systemic scleroderma	9.49e-05	0.0012	CcSEcCtD
Sofosbuvir—Musculoskeletal discomfort—Prednisone—systemic scleroderma	9.35e-05	0.00118	CcSEcCtD
Sofosbuvir—Insomnia—Prednisone—systemic scleroderma	9.28e-05	0.00117	CcSEcCtD
Sofosbuvir—Cough—Methotrexate—systemic scleroderma	9.17e-05	0.00116	CcSEcCtD
Sofosbuvir—Dyspepsia—Prednisone—systemic scleroderma	9.03e-05	0.00114	CcSEcCtD
Sofosbuvir—Nausea—Mycophenolate mofetil—systemic scleroderma	8.99e-05	0.00113	CcSEcCtD
Sofosbuvir—Chest pain—Methotrexate—systemic scleroderma	8.95e-05	0.00113	CcSEcCtD
Sofosbuvir—Myalgia—Methotrexate—systemic scleroderma	8.95e-05	0.00113	CcSEcCtD
Sofosbuvir—Arthralgia—Methotrexate—systemic scleroderma	8.95e-05	0.00113	CcSEcCtD
Sofosbuvir—Decreased appetite—Prednisone—systemic scleroderma	8.92e-05	0.00112	CcSEcCtD
Sofosbuvir—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—systemic scleroderma	8.89e-05	0.00112	CcSEcCtD
Sofosbuvir—Fatigue—Prednisone—systemic scleroderma	8.85e-05	0.00112	CcSEcCtD
Sofosbuvir—Constipation—Prednisone—systemic scleroderma	8.78e-05	0.00111	CcSEcCtD
Sofosbuvir—Infection—Methotrexate—systemic scleroderma	8.52e-05	0.00107	CcSEcCtD
Sofosbuvir—Nervous system disorder—Methotrexate—systemic scleroderma	8.41e-05	0.00106	CcSEcCtD
Sofosbuvir—Skin disorder—Methotrexate—systemic scleroderma	8.33e-05	0.00105	CcSEcCtD
Sofosbuvir—Body temperature increased—Prednisone—systemic scleroderma	8.11e-05	0.00102	CcSEcCtD
Sofosbuvir—Musculoskeletal discomfort—Methotrexate—systemic scleroderma	7.82e-05	0.000985	CcSEcCtD
Sofosbuvir—Insomnia—Methotrexate—systemic scleroderma	7.76e-05	0.000978	CcSEcCtD
Sofosbuvir—Dyspnoea—Methotrexate—systemic scleroderma	7.65e-05	0.000964	CcSEcCtD
Sofosbuvir—Dyspepsia—Methotrexate—systemic scleroderma	7.55e-05	0.000952	CcSEcCtD
Sofosbuvir—Decreased appetite—Methotrexate—systemic scleroderma	7.46e-05	0.00094	CcSEcCtD
Sofosbuvir—Gastrointestinal disorder—Methotrexate—systemic scleroderma	7.41e-05	0.000933	CcSEcCtD
Sofosbuvir—Fatigue—Methotrexate—systemic scleroderma	7.4e-05	0.000932	CcSEcCtD
Sofosbuvir—Asthenia—Prednisone—systemic scleroderma	7.36e-05	0.000928	CcSEcCtD
Sofosbuvir—Pain—Methotrexate—systemic scleroderma	7.34e-05	0.000924	CcSEcCtD
Sofosbuvir—Pruritus—Prednisone—systemic scleroderma	7.26e-05	0.000915	CcSEcCtD
Sofosbuvir—Diarrhoea—Prednisone—systemic scleroderma	7.02e-05	0.000885	CcSEcCtD
Sofosbuvir—Dizziness—Prednisone—systemic scleroderma	6.79e-05	0.000855	CcSEcCtD
Sofosbuvir—Body temperature increased—Methotrexate—systemic scleroderma	6.78e-05	0.000855	CcSEcCtD
Sofosbuvir—Vomiting—Prednisone—systemic scleroderma	6.53e-05	0.000822	CcSEcCtD
Sofosbuvir—Rash—Prednisone—systemic scleroderma	6.47e-05	0.000816	CcSEcCtD
Sofosbuvir—Dermatitis—Prednisone—systemic scleroderma	6.47e-05	0.000815	CcSEcCtD
Sofosbuvir—Headache—Prednisone—systemic scleroderma	6.43e-05	0.00081	CcSEcCtD
Sofosbuvir—Asthenia—Methotrexate—systemic scleroderma	6.15e-05	0.000776	CcSEcCtD
Sofosbuvir—Nausea—Prednisone—systemic scleroderma	6.1e-05	0.000768	CcSEcCtD
Sofosbuvir—Pruritus—Methotrexate—systemic scleroderma	6.07e-05	0.000765	CcSEcCtD
Sofosbuvir—Diarrhoea—Methotrexate—systemic scleroderma	5.87e-05	0.00074	CcSEcCtD
Sofosbuvir—Dizziness—Methotrexate—systemic scleroderma	5.67e-05	0.000715	CcSEcCtD
Sofosbuvir—Vomiting—Methotrexate—systemic scleroderma	5.45e-05	0.000687	CcSEcCtD
Sofosbuvir—Rash—Methotrexate—systemic scleroderma	5.41e-05	0.000682	CcSEcCtD
Sofosbuvir—Dermatitis—Methotrexate—systemic scleroderma	5.4e-05	0.000681	CcSEcCtD
Sofosbuvir—Headache—Methotrexate—systemic scleroderma	5.37e-05	0.000677	CcSEcCtD
Sofosbuvir—Nausea—Methotrexate—systemic scleroderma	5.1e-05	0.000642	CcSEcCtD
